Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PLGA-Mg appears to be a magnesium-incorporated form of poly(lactic-co-glycolic acid) (PLGA), which is a biodegradable copolymer widely used in drug delivery systems and tissue engineering applications. PLGA itself is FDA-approved and extensively studied for its biocompatibility and controlled release properties. ## Properties and Applications PLGA is synthesized through ring-opening co-polymerization of two monomers: lactic acid and glycolic acid. The resulting linear, aliphatic polyester can be tailored with different lactide-to-glycolide ratios to achieve specific degradation rates and mechanical properties[1][3]. When PLGA degrades in the body, it breaks down into the original monomers (lactic acid and glycolic acid), which are natural metabolic byproducts that can be eliminated through normal physiological pathways[3]. The incorporation of magnesium into PLGA likely creates a composite material with enhanced properties. Magnesium is known for its biocompatibility and potential antimicrobial properties, which could make PLGA-Mg particularly useful for applications requiring these characteristics, such as in surgical implants or wound healing devices[2]. ## Drug Delivery Applications PLGA-based systems are extensively used as drug delivery vehicles due to their ability to: - Provide controlled and sustained release of drugs - Protect drugs from premature degradation - Allow tuning of release profiles by adjusting polymer properties - Deliver various therapeutic agents including small molecules, proteins, and nucleic acids[1][2] The addition of magnesium to PLGA may enhance its antimicrobial properties, making PLGA-Mg potentially valuable for applications in surgical procedures, especially in prosthetics and implantable devices where infection prevention is crucial[2]. ## Biodegradation and Safety PLGA undergoes bulk degradation when exposed to water throughout its matrix. The degradation rate depends on factors such as: - Molecular weight - Lactide-to-glycolide ratio - Crystallinity - Drug loading - Particle size and morphology[3][5] While PLGA is generally considered safe, its degradation can create an acidic microenvironment that may affect drug stability and surrounding tissues. The pH inside degrading PLGA microspheres can become as low as 1.5, potentially creating an autocatalytic environment[3]. The incorporation of magnesium might help buffer this acidity, though specific information about this effect in PLGA-Mg is not explicitly mentioned in the search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PLGA-Mg.